VH
Schedule 13G filing
Venrock Healthcare Capital Partners III, L.P. disclosed a 11.9% stake in LYCA
Venrock Healthcare Capital Partners III, L.P. reported owning 11.9% of Lycia Therapeutics, Inc. (LYCA) (6,850,237 shares) in a Schedule 13G filed Oct 30, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 30, 2026
- Source
- Schedule 13G
More LYCA insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.